Does Rallies show 13F holders for PHGE?

Yes. Rallies tracks hedge fund and 13F ownership data for PHGE, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PHGE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHGE. It does not provide personalized investment advice.

PHGE (BiomX Inc.) Stock Analysis - Hedge Fund Holdings

BiomX Inc. (PHGE) is a publicly traded Healthcare sector company. As of May 21, 2026, PHGE trades at $0.61 with a market cap of $4.66M and a P/E ratio of 0.03. PHGE moved +56.95% today. Year to date, PHGE is -73.59%; over the trailing twelve months it is -94.25%. Its 52-week range spans $0.36 to $22.06. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces PHGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PHGE stock?

Hedge funds tracked by Rallies that own PHGE include Orbimed Advisors. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BiomX Inc..

PHGE Key Metrics

Key financial metrics for PHGE
Metric	Value
Price	$0.61
Market Cap	$4.66M
P/E Ratio	0.03
EPS	$22.19
Dividend Yield	0.00%
52-Week High	$22.06
52-Week Low	$0.36
Volume	3.87M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-36.20M
Gross Margin	0.00%

Top Hedge Funds Holding PHGE

Orbimed Advisors holds 1.79M shares of PHGE, changed +0.00% as of Mar 31, 2025.

Latest PHGE News

BiomX’s Zorronet Launches Mobile AI App Tapping $44B Command-and-Control Market — May 6, 2026
BiomX Secures Framework Deal After 98% Success in NIS 800K Rail Pilot — Apr 16, 2026
BiomX to Acquire DFSL with $12 Warrants, Adds 99%-Accurate LADAR — Apr 13, 2026
BiomX Acquires Zorronet to Target $81 Billion Defense C2 and Video Analytics Market — Apr 10, 2026
BiomX Plans $45M Acquisition of Laser-Radar Counter-Drone Developer with 99% Accuracy — Mar 31, 2026

Recent PHGE Insider Trades

Yeganeh Reuven sold 530.00K (~$2.65M) on Mar 17, 2026.
Yeganeh Reuven sold 450.00K (~$2.25M) on Mar 16, 2026.
Yeganeh Reuven sold 370.00K (~$1.85M) on Mar 13, 2026.

PHGE Analyst Consensus

1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about PHGE

Who owns PHGE stock?: Hedge funds tracked by Rallies that own PHGE include Orbimed Advisors. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BiomX Inc..
Does Rallies show 13F holders for PHGE?: Yes. Rallies tracks hedge fund and 13F ownership data for PHGE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PHGE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHGE. It does not provide personalized investment advice.